GAPDHP41

Across TCGA pan-cancer cohorts, GAPDHP41 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated GAPDHP41 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher GAPDHP41 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GAPDHP41 expression acts as an unfavorable survival marker, although some lineages such as ACC show a favorable association.

LUSC, KICH, and UCS are the cancer types where GAPDHP41 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.094	0.868	<.001	78	view →
KICH	DFS	Tertile	II,III,IV	0.043	0.950	<.001	36	view →
UCS	DFS	Tertile	IV	0.290	0.752	.028	36	view →
MESO	DFS	Tertile	All	0.153	0.479	.025	27	view →
STAD	OS	Quartile	II,III,IV	0.501	0.812	.012	26	view →
READ	OS	Tertile	IV	0.423	0.937	<.001	18	view →
DLBC	OS	Tertile	All	0.605	0.941	.034	9	view →
LIHC	DFS	Tertile	III,IV	0.082	0.338	.005	9	view →
ACC	DFS	Tertile	IV	0.577	0.248	.031	9	view →
KIRC	OS	Tertile	All	0.842	0.891	.038	6	view →
KIRP	DFS	Tertile	All	0.760	0.874	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

GAPDHP41–LUSC (DFS)

Open the LUSC breakdown →